Release Date: 09/08/12 14:55 Summary: Initial Director's Interest Notice Price Sensitive: No Download Document 272.24KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%